Detalhe da pesquisa
1.
Advances in cancer immunotherapies.
Cell
; 186(8): 1814-1814.e1, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059073
2.
Forks in the road for CAR T and CAR NK cell cancer therapies.
Nat Immunol
; 24(12): 1994-2007, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012406
3.
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies.
Cell
; 183(1): 126-142.e17, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961131
4.
Distinguishing Truncated and Normal MUC1 Glycoform Targeting from Tn-MUC1-Specific CAR T Cells: Specificity Is the Key to Safety.
Immunity
; 45(5): 947-948, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27851918
5.
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.
Immunity
; 44(2): 380-90, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26885860
6.
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
Immunity
; 44(6): 1444-54, 2016 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27332733
7.
Sweet Immune Checkpoint Targets to Enhance T Cell Therapy.
J Immunol
; 208(2): 278-285, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35017217
8.
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells.
Blood
; 135(7): 505-509, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703119
9.
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.
Immunity
; 44(3): 712, 2016 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843072
10.
Driving cars to the clinic for solid tumors.
Gene Ther
; 25(3): 165-175, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880908
11.
Glycan-directed CAR-T cells.
Glycobiology
; 28(9): 656-669, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370379
12.
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells.
Blood
; 124(7): 1070-80, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24986688
13.
EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development.
Dev Biol
; 387(2): 179-90, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24440153
14.
Therapeutic intersections: Expanding benefits of CD19 CAR T cells from cancer to autoimmunity.
Cell Stem Cell
; 31(4): 437-438, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38579681
15.
Chimeric Antigen Receptor T-Cell Therapy: Current Perspective on T Cell-Intrinsic, T Cell-Extrinsic, and Therapeutic Limitations.
Cancer J
; 29(1): 28-33, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693155
16.
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma.
Blood Adv
; 7(14): 3416-3430, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058474
17.
Targeting Solid Cancers with a Cancer-Specific Monoclonal Antibody to Surface Expressed Aberrantly O-glycosylated Proteins.
Mol Cancer Ther
; 22(10): 1204-1214, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451822
18.
Endocytic recycling proteins EHD1 and EHD2 interact with fer-1-like-5 (Fer1L5) and mediate myoblast fusion.
J Biol Chem
; 286(9): 7379-88, 2011 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21177873
19.
20.
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety.
Cancer Cell
; 40(12): 1470-1487.e7, 2022 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513049